On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

GATM

glycine amidinotransferase

The GATM gene encodes an enzyme crucial for the initial step in creatine biosynthesis, a compound vital for cellular energy storage and utilisation. GATM provides instructions for the enzyme arginine:glycine amidinotransferase.

Chromosome 15q21.1 Polygenic HGNC:4175 Tier C
GATM 15q21.1 p arm q arm 15

GATM is located on the long (q) arm of chromosome 15, at band 15q21.1. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 15 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The GATM gene, also known as glycine amidinotransferase, plays a fundamental role in human metabolism by coding for an enzyme called arginine:glycine amidinotransferase. This enzyme is specifically involved in the biosynthesis pathway of creatine, a molecule critical for energy supply in cells, particularly in tissues with high energy demands like muscles and the brain. Proper functioning of the GATM enzyme ensures the efficient production of creatine, which is then converted into phosphocreatine for rapid energy buffering and transfer.

What the gene does

The GATM gene provides the blueprint for the enzyme arginine:glycine amidinotransferase, often referred to as AGAT. This enzyme catalyses the first of two key steps in the body's endogenous creatine synthesis pathway. Specifically, AGAT facilitates the transfer of a guanidino group from arginine, an amino acid, to glycine, another amino acid. This reaction yields guanidinoacetic acid (GAA). Subsequently, GAA is converted to creatine in a separate enzymatic step. Creatine is essential for the storage and efficient utilisation of energy within cells, supporting vital physiological processes. Deficiencies in GATM activity can disrupt this pathway, leading to insufficient creatine levels.

Video: Genetics 101

Chromosome location

The GATM gene is situated on chromosome 15 at band 15q21.1. This precise location specifies where the gene can be found within the human genome. The protein it encodes is composed of 423 amino acids, contributing to its enzymatic function in creatine synthesis.

Protein structure

Domain architecture has not been experimentally characterised in detail for this protein.

Key variants

Genetic variations within the GATM gene can alter the function of the arginine:glycine amidinotransferase enzyme. These changes can range from small alterations in the DNA sequence to larger structural rearrangements. Such variants may lead to a reduced or absent enzyme function, thereby impacting the body's ability to produce creatine effectively. The specific impact of a variant often depends on its location and the nature of the genetic change.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for GATM.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.1111dup
Duplication
p.Met371fs Pathogenic ★★★☆ Arginine:glycine amidinotransferase deficiency
c.446G>A
single nucleotide variant
p.Trp149Ter Pathogenic ★★★☆ Arginine:glycine amidinotransferase deficiency
c.484+1G>T
single nucleotide variant
- Pathogenic ★★★☆ Arginine:glycine amidinotransferase deficiency
c.505C>T
single nucleotide variant
p.Arg169Ter Pathogenic ★★★☆ Arginine:glycine amidinotransferase deficiency
c.629G>A
single nucleotide variant
p.Trp210Ter Pathogenic ★★★☆ Arginine:glycine amidinotransferase deficiency
c.580C>T
single nucleotide variant
p.Arg194Ter Pathogenic/Likely pathogenic ★★☆☆ Arginine:glycine amidinotransferase deficiency
g.(?_45661504)_(45670651_?)del
Deletion
- Pathogenic ★☆☆☆ Arginine:glycine amidinotransferase deficiency
c.141dup
Duplication
p.Asn48fs Pathogenic ★☆☆☆ Arginine:glycine amidinotransferase deficiency
c.92G>A
single nucleotide variant
p.Trp31Ter Pathogenic ★☆☆☆ Arginine:glycine amidinotransferase deficiency
c.964C>T
single nucleotide variant
p.Arg322Ter Pathogenic ★☆☆☆ Arginine:glycine amidinotransferase deficiency

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Variants in the GATM gene are associated with inherited metabolic disorders, notably those affecting creatine metabolism. One such condition is Cerebral creatine deficiency (AGAT), which can arise from insufficient activity of the GATM enzyme. This deficiency leads to a lack of creatine in the brain and other tissues, resulting in neurological symptoms.

UK clinical status

The GATM gene is recognised by NHS England's National Genomic Test Directory. It is included in several Green R-panels, indicating its relevance for diagnosing conditions such as Intellectual disability, Likely inborn error of metabolism (R98), Renal tubulopathies (R198), Tubulointerstitial kidney disease (R202), and Undiagnosed metabolic disorders. This widespread inclusion underscores the clinical significance of GATM in the UK healthcare system.

Frequently asked questions

What does the GATM gene do?

The GATM gene provides instructions for making the arginine:glycine amidinotransferase enzyme, which is responsible for the first step in the body's natural production of creatine. Creatine is vital for storing and using energy in cells, especially in the brain and muscles.

What conditions are associated with GATM gene variants?

Variants in the GATM gene are primarily associated with conditions like Cerebral creatine deficiency (AGAT), which can lead to neurological issues due to insufficient creatine levels in the brain.

Is GATM testing available in the UK?

Yes, the GATM gene is included in several NHS England Genomic Test Directory panels, such as those for Intellectual disability and specific metabolic disorders, indicating its importance for diagnostic testing in the UK.

References

  1. Braissant O, Henry H, Béard E. Creatine deficiency syndromes and the importance of creatine synthesis in the brain. Amino acids. 2011. PMID: 21390529
  2. Nasrallah F, Feki M, Kaabachi N. Creatine and creatine deficiency syndromes: biochemical and clinical aspects. Pediatric neurology. 2010. PMID: 20159424
  3. Béard E, Braissant O. Synthesis and transport of creatine in the CNS: importance for cerebral functions. Journal of neurochemistry. 2010. PMID: 20796169
  4. Morris SM Jr. Enzymes of arginine metabolism. The Journal of nutrition. 2004. PMID: 15465778
  5. Sykut-Cegielska J, Gradowska W, Mercimek-Mahmutoglu S. Biochemical and clinical characteristics of creatine deficiency syndromes. Acta biochimica Polonica. 2004. PMID: 15625559
  6. Schulze A. Creatine deficiency syndromes. Molecular and cellular biochemistry. 2003. PMID: 12701824
  7. Item CB, Stöckler-Ipsiroglu S, Stromberger C. Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. American journal of human genetics. 2001. PMID: 11555793
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 4 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .